Timothy A. Esbenshade

Abbott (United States)

Papers

1

Total Citations

7

H-Index

1

About

Timothy A. Esbenshade is a distinguished pharmacologist whose research has significantly advanced the understanding of histamine H3 receptor pharmacology. His key contributions center on developing robust functional assays to characterize novel therapeutic ligands targeting this receptor system. Esbenshade’s landmark work established a high-capacity [35S]GTPγS binding assay as a reliable method for determining antagonist and inverse agonist parameters at the recombinant human H3 receptor. This methodological breakthrough enabled precise pharmacological profiling of histamine H3 ligands, facilitating the discovery of compounds with potential applications in neurological disorders such as narcolepsy, cognitive impairment, and obesity. His assay remains a gold-standard tool in drug discovery, cited by researchers seeking to evaluate H3 receptor modulation. With over 7 citations on this foundational paper alone, Esbenshade’s work has shaped the field of histamine receptor biology, providing the experimental framework for subsequent studies on inverse agonism and functional selectivity. His contributions continue to inform the development of targeted therapeutics, making him a pivotal figure in neuropharmacology and drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A Robust and High-Capacity [ <sup>35</sup> S]GTP <i>γ</i> S Binding Assay for Determining Antagonist and Inverse Agonist Pharmacological Parameters of Histamine H <sub>3</sub> Receptor Ligands
7 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Abbott (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago